Pricing Log in Create free account

Biohaven Ltd. (BHVN) vs Immunome, Inc. (IMNM)

Biohaven Ltd. and Immunome, Inc. are both Biotechnology companies. Biohaven Ltd. and Immunome, Inc. are of similar size ($2.1B and $2.1B). Biohaven Ltd. grew revenue faster over the last twelve months: 425.2% against 16.7%. Across the 13 metrics below, Immunome, Inc. leads on 7 and Biohaven Ltd. on 6.

Valuation

Metric BHVN IMNM Biotechnology median
P/E n/m n/m 10.26
P/S 2.13 162.50 9.18
P/B n/m 3.90 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m n/m 0.65
EV/Sales 2.23 121.23 8.98
Earnings yield (27.50%) (14.01%) (34.89%)
Free cash flow yield (23.27%) (10.71%) (24.52%)

Profitability

Metric BHVN IMNM Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 940.46% (64.03%) (50.12%)
Return on assets (161.32%) (59.03%) (45.60%)
Return on invested capital (6,659.91%) (3,322.99%) 0.00%

Growth

Metric BHVN IMNM Biotechnology median
Revenue growth (TTM) 425.20% 16.74% 6.26%
EPS growth (last fiscal year) 26.08% 51.40% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BHVN IMNM Biotechnology median
Debt to equity (2.69) 0.00 0.00
Current ratio 3.05 15.08 4.89
Net debt to EBITDA 0.11 2.92 1.01

Dividend

Metric BHVN IMNM Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BHVN IMNM Biotechnology median
Market cap 2.10b 2.11b 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack